Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
2.030
+0.190 (10.33%)
Nov 21, 2024, 1:12 PM EST - Market open
Quince Therapeutics Market Cap
Quince Therapeutics has a market cap or net worth of $89.33 million as of November 21, 2024. Its market cap has increased by 116.86% in one year.
Market Cap
89.33M
Enterprise Value
48.47M
1-Year Change
116.86%
Ranking
Category
Stock Price
$2.03
Market Cap Chart
Since May 9, 2019, Quince Therapeutics's market cap has decreased from $855.58M to $89.33M, a decrease of -89.56%. That is a compound annual growth rate of -33.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 77.88M | 73.03% |
| Dec 29, 2023 | 45.01M | 95.46% |
| Dec 30, 2022 | 23.03M | -93.89% |
| Dec 31, 2021 | 377.06M | -53.99% |
| Dec 31, 2020 | 819.45M | -45.64% |
| Dec 31, 2019 | 1.51B | 76.20% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Renovaro | 79.33M |
| Clearside Biomedical | 78.12M |
| P3 Health Partners | 78.02M |
| I-Mab | 77.37M |
| OptimizeRx | 77.18M |
| ESSA Pharma | 76.54M |
| Oncolytics Biotech | 76.26M |
| Aerovate Therapeutics | 75.94M |